July 19, 2018
FDA finalizes guidance for use of EHR data in clinical studies
Editor's Note
The Food and Drug Administration (FDA) on July 19 finalized its guidance for using electronic health record (EHR) data in FDA-regulated clinical studies.
The guidance is meant to encourage the use of EHR data in clinical studies and promote greater interoperability between EHR and electronic data capture systems.
The guidance provides recommendations to sponsors, clinical investigators, clinical research organizations, institutional review boards, and others interested in using EHR data in clinical investigations.
Free Daily News
- Study: Excessive nurse overtime, agency staffing harm patients
- Commentary: Technology no substitute for cadaver-based medical education
- Study: Early-stage breast cancer surgery may not be necessary after chemo, radiation
- Experimental brain implant translates thoughts to speech
- Nurses deem flexible, transparent scheduling key to satisfaction, retention
- OR Manager 2025 Career/Salary Survey offers opportunities to learn, give back
- The Joint Commission revises volume criteria for cardiac, stroke certifications
- Pulse oximetry monitoring at home found to save lives of high-risk opioid surgery patients
- New data suggest same-day discharge is safe for joint replacement patients with atrial fibrillation
- FBI investigates as Oracle health data breach exposes patient information
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement